Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jan;35(1):23–26. doi: 10.1136/gut.35.1.23

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

M Fried 1, H Siegrist 1, R Frei 1, F Froehlich 1, P Duroux 1, J Thorens 1, A Blum 1, J Bille 1, J J Gonvers 1, K Gyr 1
PMCID: PMC1374626  PMID: 8307444

Abstract

The extent of duodenal bacterial overgrowth during the pronounced inhibition of acid secretion that occurs with omeprazole treatment is unknown. The bacterial content of duodenal juice of patients treated with omeprazole was therefore examined in a controlled prospective study. Duodenal juice was obtained under sterile conditions during diagnostic upper endoscopy. Aspirates were plated quantitatively for anaerobic and aerobic organisms. Twenty five outpatients with peptic ulcer disease were investigated after a 5.7 (0.5) weeks (mean (SEM)) treatment course with 20 mg (nine patients) or 40 mg (16 patients). The control group consisted of 15 outpatients referred for diagnostic endoscopy without prior antisecretory treatment. No patient in the control group had duodenal bacterial overgrowth. In the omeprazole group bacterial overgrowth (> or = 10(5) cfu/ml) was found in 14 (56%) patients (p = 0.0003). The number of bacteria (log10) in duodenal juice in patients treated with omeprazole was distinctly higher (median 5.7; range < 2-8.7) when compared with the control group (median < 2; range < 2-5.0; p = 0.0004). As well as orally derived bacteria, faecal type bacteria were found in seven of 14 and anaerobic bacteria in three of 14 patients. Bacterial overgrowth was similar with the two doses of omeprazole. These results indicate that duodenal bacterial overgrowth of both oral and faecal type bacteria occurs often in ambulatory patients treated with omeprazole. Further studies are needed to determine the clinical significance of these findings, particularly in high risk groups during long term treatment with omeprazole.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armbrecht U., Seeberg S., Stockbrügger R. W. Hydrogen (H2) breath excretion in peptic disease before and during treatment with ranitidine. Scand J Gastroenterol. 1987 Dec;22(10):1211–1216. doi: 10.3109/00365528708996466. [DOI] [PubMed] [Google Scholar]
  2. Bardhan P. K., Gyr K., Beglinger C., Vögtlin J., Frey R., Vischer W. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol. 1992;27(3):253–256. doi: 10.3109/00365529208999959. [DOI] [PubMed] [Google Scholar]
  3. Bourne J. T., Mountford R. A., Barry R. E. Twice-daily cimetidine does not increase gastric bacterial flora. Postgrad Med J. 1984 Jul;60(705):464–466. doi: 10.1136/pgmj.60.705.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corazza G. R., Menozzi M. G., Strocchi A., Rasciti L., Vaira D., Lecchini R., Avanzini P., Chezzi C., Gasbarrini G. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990 Feb;98(2):302–309. doi: 10.1016/0016-5085(90)90818-l. [DOI] [PubMed] [Google Scholar]
  5. Cristiano P., Paradisi F. Can cimetidine facilitate infections by oral route. Lancet. 1982 Jul 3;2(8288):45–45. doi: 10.1016/s0140-6736(82)91179-5. [DOI] [PubMed] [Google Scholar]
  6. Drasar B. S., Shiner M., McLeod G. M. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology. 1969 Jan;56(1):71–79. [PubMed] [Google Scholar]
  7. Drasar B. S., Shiner M. Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut. 1969 Oct;10(10):812–819. doi: 10.1136/gut.10.10.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Driks M. R., Craven D. E., Celli B. R., Manning M., Burke R. A., Garvin G. M., Kunches L. M., Farber H. W., Wedel S. A., McCabe W. R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. doi: 10.1056/NEJM198711263172204. [DOI] [PubMed] [Google Scholar]
  9. El Masri S. H., Okosdonossian E. T., Boulos P. B. The clinical significance of gastric acid secretion in bilharzial hepatic fibrosis. Br J Surg. 1982 Nov;69(11):644–645. doi: 10.1002/bjs.1800691105. [DOI] [PubMed] [Google Scholar]
  10. Enander L. K., Nilsson F., Rydén A. C., Schwan A. The aerobic and anaerobic microflora of the gastric remnant more than 15 years after Billroth II resection. Scand J Gastroenterol. 1982 Sep;17(6):715–720. doi: 10.3109/00365528209181084. [DOI] [PubMed] [Google Scholar]
  11. Forster A., Niethamer T., Suter P., Pitteloud J. J., Intante F., Ducel G., Morel D. Influence de la cimétidine sur la croissance bactérienne dans le liquide gastrique. Nouv Presse Med. 1982 Jun 26;11(30):2281–2283. [PubMed] [Google Scholar]
  12. Garvey B. M., McCambley J. A., Tuxen D. V. Effects of gastric alkalization on bacterial colonization in critically ill patients. Crit Care Med. 1989 Mar;17(3):211–216. doi: 10.1097/00003246-198903000-00002. [DOI] [PubMed] [Google Scholar]
  13. Gilman R. H., Partanen R., Brown K. H., Spira W. M., Khanam S., Greenberg B., Bloom S. R., Ali A. Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. Gastroenterology. 1988 Jun;94(6):1308–1314. doi: 10.1016/0016-5085(88)90668-3. [DOI] [PubMed] [Google Scholar]
  14. Gray J. D., Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut. 1967 Dec;8(6):574–581. doi: 10.1136/gut.8.6.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamilton I., Worsley B. W., O'Connor H. J., Axon A. T. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut. 1983 Dec;24(12):1148–1151. doi: 10.1136/gut.24.12.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hillman K. M., Riordan T., O'Farrell S. M., Tabaqchali S. Colonization of the gastric contents in critically ill patients. Crit Care Med. 1982 Jul;10(7):444–447. doi: 10.1097/00003246-198207000-00005. [DOI] [PubMed] [Google Scholar]
  17. Howden C. W., Hunt R. H. Relationship between gastric secretion and infection. Gut. 1987 Jan;28(1):96–107. doi: 10.1136/gut.28.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lind T., Cederberg C., Olausson M., Olbe L. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology. 1990 Dec;99(6):1593–1598. doi: 10.1016/0016-5085(90)90462-a. [DOI] [PubMed] [Google Scholar]
  19. Milton-Thompson G. J., Lightfoot N. F., Ahmet Z., Hunt R. H., Barnard J., Bavin P. M., Brimblecombe R. W., Darkin D. W., Moore P. J., Viney N. Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet. 1982 May 15;1(8281):1091–1095. doi: 10.1016/s0140-6736(82)92277-2. [DOI] [PubMed] [Google Scholar]
  20. Muscroft T. J., Youngs D. J., Burdon D. W., Keighley M. R. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet. 1981 Feb 21;1(8217):408–410. doi: 10.1016/s0140-6736(81)91791-8. [DOI] [PubMed] [Google Scholar]
  21. Olbe L., Cederberg C., Lind T., Olausson M. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol Suppl. 1989;166:27–42. doi: 10.3109/00365528909091240. [DOI] [PubMed] [Google Scholar]
  22. Prewett E. J., Hudson M., Nwokolo C. U., Sawyerr A. M., Pounder R. E. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology. 1991 Apr;100(4):873–877. doi: 10.1016/0016-5085(91)90258-m. [DOI] [PubMed] [Google Scholar]
  23. Reusser P., Zimmerli W., Scheidegger D., Marbet G. A., Buser M., Gyr K. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis. 1989 Sep;160(3):414–421. doi: 10.1093/infdis/160.3.414. [DOI] [PubMed] [Google Scholar]
  24. Ruddell W. S., Axon A. T., Findlay J. M., Bartholomew B. A., Hill M. J. Effect of cimetidine on the gastric bacterial flora. Lancet. 1980 Mar 29;1(8170):672–674. [PubMed] [Google Scholar]
  25. Ruddell W. S., Losowsky M. S. Severe diarrehoea due to small intestinal colonisation during cimetidine treatment. Br Med J. 1980 Jul 26;281(6235):273–273. doi: 10.1136/bmj.281.6235.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sarker S. A., Gyr K. Non-immunological defence mechanisms of the gut. Gut. 1992 Jul;33(7):987–993. doi: 10.1136/gut.33.7.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sharma B. K., Santana I. A., Wood E. C., Walt R. P., Pereira M., Noone P., Smith P. L., Walters C. L., Pounder R. E. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984 Sep 22;289(6447):717–719. doi: 10.1136/bmj.289.6447.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sherman P., Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis. 1987;5(3):157–171. doi: 10.1159/000171170. [DOI] [PubMed] [Google Scholar]
  29. Simon G. L., Gorbach S. L. Intestinal flora in health and disease. Gastroenterology. 1984 Jan;86(1):174–193. [PubMed] [Google Scholar]
  30. Snepar R., Poporad G. A., Romano J. M., Kobasa W. D., Kaye D. Effect of cimetidine and antacid on gastric microbial flora. Infect Immun. 1982 May;36(2):518–524. doi: 10.1128/iai.36.2.518-524.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stockbrugger R. W., Cotton P. B., Eugenides N., Bartholomew B. A., Hill M. J., Walters C. L. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut. 1982 Dec;23(12):1048–1054. doi: 10.1136/gut.23.12.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stockbrügger R. W., Cronstedt J., Dotevall G., Hellner L., Hoffmann P., Hradsky M., Jaup B. H., Seeberg S. The intragastric milieu during gastric ulcer treatment with pirenzepine 50 mg b.i.d. or cimetidine 400 mg b.i.d. Z Gastroenterol. 1988 Nov;26(11):685–688. [PubMed] [Google Scholar]
  33. Taylor D. N., Bied J. M., Munro J. S., Feldman R. A. Salmonella dublin infections in the United States, 1979-1980. J Infect Dis. 1982 Sep;146(3):322–327. doi: 10.1093/infdis/146.3.322. [DOI] [PubMed] [Google Scholar]
  34. Thomas J. M., Misiewicz J. J., Cook A. R., Hill M. J., Smith P. L., Walters C. L., Forster J. K., Martin L. E., Woodings D. F. Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut. 1987 Jun;28(6):726–738. doi: 10.1136/gut.28.6.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Toeg A., Berger S. A., Battat A., Hoffman M., Yust I. Vibrio cholerae bacteremia associated with gastrectomy. J Clin Microbiol. 1990 Mar;28(3):603–604. doi: 10.1128/jcm.28.3.603-604.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Unreviewed reports. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1272–1272. [PMC free article] [PubMed] [Google Scholar]
  37. Wingate D. L. Acid reduction and recurrent enteritis. Lancet. 1990 Jan 27;335(8683):222–222. doi: 10.1016/0140-6736(90)90309-s. [DOI] [PubMed] [Google Scholar]
  38. du Moulin G. C., Paterson D. G., Hedley-Whyte J., Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet. 1982 Jan 30;1(8266):242–245. doi: 10.1016/s0140-6736(82)90974-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES